You can help researchers imrprove public health by volunteering for NIAID clinical studies.
There are more than 150 different forms of primary immune deficiency diseases (PIDDs) and, though they affect only about 500,000 people in the United States, these diseases are chronic and debilitating. Since the 1980s NIAID-supported investigators have been examining the causes and complications of PIDDs to improve the lives of patients and families affected by these conditions.
NIAID aims to improve diagnosis, facilitate genetic counseling, and explore new treatments and preventions for PIDDs. It is home to a Primary Immune Deficiency Clinic, which provides diagnoses and disease management recommendations to those whose lives are touched by PIDDs.
Tipsheet: 2012 Annual Meeting of the American Academy of Allergy, Asthma & Immunology—March 7, 2012
NIH Scientists Find Cause of Rare Immune Disease—Jan. 11, 2012
Media Availability: To Treat Rare Disease, NIH Scientists Repurpose FDA-Approved Drug—Sept. 2, 2011
Trace Amounts of Germ-killing Molecules Predict Disease Survival—Dec. 29, 2010
View all PIDD News and Events
News from NIAID-Supported Institutions
Last Updated July 18, 2012
Last Reviewed June 08, 2011